CoreCivic (CXW) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Q3 2024 revenue was $491.6 million, up 2% year-over-year, with net income rising 52% to $21.1 million and adjusted EBITDA up 11% to $83.3 million; nine-month revenue was $1,482.4 million, up 5.5% year-over-year.
Normalized FFO per share rose 23% to $0.43, and AFFO per share was $0.42; diluted EPS was $0.19.
Federal partners, mainly ICE and US Marshals, contributed just over half of total revenue; ICE revenue declined 3.4% but increased 10.9% excluding South Texas Family Residential Center, which was terminated in August 2024.
State and local revenues grew, with new contracts in Wyoming, Montana, Hinds County (MS), and Harris County (TX) boosting results.
Occupancy in Safety and Community segments rose to 75.2% from 72% year-over-year, supporting margin improvement.
Financial highlights
Q3 2024 net income was $21.1 million ($0.19/share), up from $13.9 million in Q3 2023; adjusted EPS was $0.20.
Adjusted EBITDA was $83.3 million, up from $75.2 million in Q3 2023.
Operating margin in Safety and Community segments improved to 24.9% from 21.3% year-over-year.
Debt was reduced by $75.6 million in Q3; leverage at 2.2x net debt/EBITDA, below the long-term target.
$108 million cash on hand and $257 million available on a revolver, totaling $365 million in liquidity.
Outlook and guidance
2024 adjusted EPS guidance raised to $0.69–$0.75; normalized FFO per share to $1.59–$1.65; net income guidance raised to $55.5–$61.5 million.
Guidance assumes stable federal populations; upside possible if detention populations rise.
AFFO expected at $177.8–$185.8 million ($1.58–$1.65/share), up from prior guidance.
Maintenance capex for 2024 unchanged at $62–$66 million; total capex expected at $70–$76 million.
Management prioritizes debt reduction over share repurchases following ICE contract termination.
Latest events from CoreCivic
- Q4 2025 delivered robust growth, record ICE demand, and strong 2026 guidance with ample capacity.CXW
Q4 202512 Feb 2026 - Q2 revenue and earnings rose, but ICE contract loss will impact future results and capital priorities.CXW
Q2 20242 Feb 2026 - Q2 2025 delivered double-digit growth and raised guidance on record ICE demand and new contracts.CXW
Q2 202516 Jan 2026 - Q3 2025 revenue up 18.1% to $580.4M, net income up 24.7%, driven by ICE contracts.CXW
Q3 202516 Jan 2026 - Q1 2025 net income rose to $25.1M, guidance raised on strong demand and facility activations.CXW
Q1 202516 Jan 2026 - 2024 results beat forecasts; strong cash flow and new contracts set up growth for 2025.CXW
Q4 202416 Jan 2026 - Annual meeting to vote on directors, auditor, executive pay, and highlight ESG and governance.CXW
Proxy Filing1 Dec 2025 - Virtual annual meeting to elect directors, ratify auditor, and approve executive pay.CXW
Proxy Filing1 Dec 2025 - Significant idle capacity and new ICE contracts position the company for strong EBITDA growth.CXW
Noble Capital Markets Emerging Growth Virtual Equity Conference11 Nov 2025